Monopar Therapeutics (MNPR) EPS (Basic) Growth (1y) (2018 - 2025)
Monopar Therapeutics (MNPR) EPS (Basic) Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 112.82% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -42.99% |
| Jun 30, 2025 | 27.77% |
| Mar 31, 2025 | 13.54% |
| Sep 30, 2024 | 39.42% |
| Jun 30, 2024 | 41.72% |
| Mar 31, 2024 | 43.90% |
| Sep 30, 2023 | 26.79% |
| Jun 30, 2023 | 22.39% |
| Mar 31, 2023 | 2.68% |
| Dec 31, 2022 | -26.53% |
| Sep 30, 2022 | 3.29% |
| Jun 30, 2022 | -35.44% |
| Mar 31, 2022 | -25.14% |
| Dec 31, 2021 | -22.16% |
| Sep 30, 2021 | -31.83% |
| Jun 30, 2021 | -21.06% |
| Mar 31, 2021 | -45.75% |
| Dec 31, 2020 | -67.77% |
| Sep 30, 2020 | -79.58% |
| Jun 30, 2020 | -34.87% |